ArticleDiagnostics (Basel, Switzerland)2022
Biomedical Diagnosis of Breast Cancer Using Deep Learning and Multiple Classifiers.
Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.
- Artificial intelligence in breast ultrasound: a systematic review of research advances.Frontiers in oncology · 2025Pooled it
- Extracting Knowledge from Machine Learning Models to Diagnose Breast Cancer.Life (Basel, Switzerland) · 2025Article
- Benign and Malignant Breast Tumor Classification in Ultrasound and Mammography Images via Fusion of Deep Learning and Handcraft Features.Entropy (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
Breast cancer is considered one of the deadliest diseases in women. Due to the risk and threat it poses, the world has agreed to hold a breast cancer awareness day in October, encouraging women to perform mammogram inspections. This inspection may prevent breast-cancer-related deaths or reduce the death rate. The identification and classification of breast cancer are challenging tasks. The most commonly known procedure of breast cancer detection is performed by using mammographic images. Recently implemented algorithms suffer from generating accuracy below expectations, and their computational complexity is high. To resolve these issues, this paper proposes a fully automated biomedical diagnosis system of breast cancer using an AlexNet, a type of Convolutional Neural Network (CNN), and multiple classifiers to identify and classify breast cancer. This system utilizes a neuro-fuzzy method, a segmentation algorithm, and various classifiers to reach a higher accuracy than other systems have achieved. Numerous features are extracted to detect and categorize breast cancer. Three datasets from Kaggle were tested to validate the proposed system. The performance evaluation is performed with quantitative and qualitative accuracy, precision, recall, specificity, and F-score. In addition, a comparative assessment is performed between the proposed system and some works of literature. This assessment shows that the presented algorithm provides better classification results and outperforms other systems in all parameters. Its average accuracy is over 98.6%, while other metrics are more than 98%. This research indicates that this approach can be applied to assist doctors in diagnosing breast cancer correctly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.